Clinical Site

New York, New York 10128

1 studies enrolling now · 13 studies all time

What they study most

Acne Inversa, Age-related Macular Degeneration, Bipolar Depression, C3 Glomerulopathy (C3G), Cardiovascular Disease, Elevated Lipoprotein(a), Hidradenitis Suppurativa, In-situ Small Bowel T-cell Lymphoma, Major Depressive Disorder, Neovascular Age-related Macular Degeneration, Respiratory Syncytial Virus Infections, Type II Refractory Celiac Disease (RCD-II)

Studies at this site

• A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) — Completed
• A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa — Enrolling by invitation
• Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
• Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression — Completed
• Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder — Completed
• Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) — Completed
• Controlled Trial Evaluating Avacopan in C3 Glomerulopathy — Completed
• Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa — Completed
• Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression — Completed
• Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease — Completed
• Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease — Completed
• Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) — Completed